Emerging optical techniques in advanced cystoscopy for bladder cancer diagnosis: A review of the current literature

Indian Journal of Urology

Volumn 27, Issue 2, 2011, Pages 245-251

  Cauberg Evelyne, C C ^a   De La Rosette Jean, J M C H ^a   De Reijke Theo, M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Diagnosis; fluorescence cystoscopy; imaging; narrow band imaging; nonmuscle invasive bladder cancer; optical coherence tomography; photodynamic diagnosis; urothelial carcinoma

Indexed keywords

BLADDER CANCER; CANCER DIAGNOSIS; CONFERENCE PAPER; CYSTOSCOPY; DIAGNOSTIC ACCURACY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MALE; MEDICAL RECORD REVIEW; NARROW BAND IMAGING; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; SENSITIVITY AND SPECIFICITY; TRANSURETHRAL RESECTION;

EID: 79960685757     PISSN: 09701591     EISSN: 19983824     Source Type: Journal    
DOI: 10.4103/0970-1591.82845     Document Type: Conference Paper

References (51)

1. van Rhijn BW, Burger M, Lotan Y, Solsona E, Stief CG, Sylvester RJ, et al. Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. Eur Urol 2009;56:430-42.
2. Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006;49:466-475. (Pubitemid 43259554)
3. Madeb R, Golijanin D, Knopf J, Messing EM. Current state of screening for bladder cancer. Expert Rev Anticancer Ther 2007;7:981-7. (Pubitemid 47180900)
4. Lokeshwar VB, Soloway MS. Current bladder tumor tests: does their projected utility fulfill clinical necessity? J Urol 2001;165:1067-77. (Pubitemid 32210202)
5. Lokeshwar VB, Habuchi T, Grossman HB, Murphy WM, Hautmann SH, Hemstreet GP, et al. Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers. Urology 2005;66:35-63. (Pubitemid 43049608)
6. Kivrak AS, Kiresi D, Emlik D, Odev K, Kilinc M. Comparison of CT virtual cystoscopy of the contrast material-filled bladder with conventional cystoscopy in the diagnosis of bladder tumours. Clin Radiol 2009;64:30-7.
7. Koplay M, Kantarci M, Guven F, Aksoy Y, Taser F, Ziypak T, et al. Diagnostic efficiency of multidetector computed tomography with multiplanar reformatted imaging and virtual cystoscopy in the assessment of bladder tumors after transurethral resection. J Comput Assist Tomogr 2010;34:121-6.
8. Bush RB, Leonhardt H, Bush IV, Landes RR. Dr. Bozzini's Lichtleiter. A translation of his original article (1806). Urology 1974;3:119-23.
9. Natalin RA, Landman J. Where next for the endoscope? Nat Rev Urol 2009;6:622-8.
10. Jocham D, Stepp H, Waidelich R. Photodynamic Diagnosis in Urology: State-of-the-Art. Eur Urol 2008;53:1138-50.
11. Brausi M, Collette L, Kurth K, van der Meijden AP, Oosterlinck W, et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 2002;41:523-31.
12. Cina SJ, Epstein JI, Endrizzi JM, Harmon WJ, Seay TM, Schoenberg MP. Correlation of cystoscopic impression with histologic diagnosis of biopsy specimens of the bladder. Hum Pathol 2001;32:630-7. (Pubitemid 32601245)
13. Soloway MS. Expectant treatment of small, recurrent, low-grade, noninvasive tumors of the urinary bladder. Urol Oncol 2006;24:58-61. (Pubitemid 43097359)
14. Zaak D, Kriegmair M, Stepp H, Stepp H, Baumgartner R, Oberneder R, et al. Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopies. Urology 2001;57:690-4.
15. Hungerhuber E, Stepp H, Kriegmair M, Stief C, Hofstetter A, Hartmann A, et al. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder. Urology 2007;69:260-4. (Pubitemid 46274934)
16. Grossman HB, Gomella L, Fradet Y, Morales A, Presti J, Ritenour C, et al. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. J Urol 2007;178:62-7. (Pubitemid 46908731)
17. Fradet Y, Grossman HB, Gomella L, Lerner S, Cookson M, Albala D, et al. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. J Urol 2007;178:68-73. (Pubitemid 46908730)
18. Schmidbauer J, Witjes F, Schmeller N, Donat R, Susani M, Marberger M. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol 2004;171:135-8. (Pubitemid 37549108)
19. Kausch I, Sommerauer M, Montorsi F, Stenzl A, Jacqmin D, Jichlinski P, et al. Photodynamic Diagnosis in Non-Muscle-Invasive Bladder Cancer: A Systematic Review and Cumulative Analysis of Prospective Studies. Eur Urol 2010;57:595-606.
20. Grimbergen MC, van Swol CF, Jonges TG, Boon TA, van Moorselaar RJ. Reduced specificity of 5-ALA induced fluorescence in photodynamic diagnosis of transitional cell carcinoma after previous intravesical therapy. Eur Urol 2003;44:51-6. (Pubitemid 36741375)
21. Draga RO, Grimbergen MC, Kok ET, Jonges TN, van Swol CF, Bosch JL. Photodynamic Diagnosis (5-Aminolevulinic Acid) of Transitional Cell Carcinoma After Bacilus Calmette-Guerin Immunotherapy and Mitomycin C Intravesical Therapy. Eur Urol 2010;57655-60.
22. Mynderse LM, Rochester MN, Stenzl A, Denzinger S, Fradet Y, Soloway MS, et al. Hexaminolevulinate fluorescence cystoscopy improves detection and resection of papillary bladder cancer lesions and reduces early recurrences. 2009.
23. Denzinger S, Burger M, Walter B, Knuechel R, Roessler W, Wieland WF, et al. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study. Urology 2007;69:675-9. (Pubitemid 46574917)
24. Daniltchenko DI, Riedl CR, Sachs MD, Koenig F, Daha KL, Pflueger H, et al. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study. J Urol 2005;174:2129-33. (Pubitemid 41611752)
25. Burger M, Zaak D, Stief CG, Filbeck T, Wieland WF, Roessler W, et al. Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis. Eur Urol 2007;52:142-7. (Pubitemid 46803019)
26. Mowatt G, Zhu S, Kilonzo M, Boachie C, Fraser C, Griffiths TR, et al. Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer. Health Technol Assess 2010;14:1-4.
27. Zaak D, Wieland WF, Stief C, Burger M. Routine Use of Photodynamic Diagnosis of Bladder Cancer: Practical and Economic Issues. European Urology supplements 2008;7:536-41.
28. Kuznetsov K, Lambert R, Rey JF. Narrow-band imaging: potential and limitations. Endoscopy 2006;38:76-81. (Pubitemid 43092707)
29. Song LM, Adler DG, Conway JD, Diehl DL, Farraye FA, Kantsevoy SV, et al. Narrow band imaging and multiband imaging. Gastrointest Endosc 2008;67:581-9. (Pubitemid 351406354)
30. Bryan RT, Billingham LJ, Wallace DM. Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder. BJU Int 2008;101:702-05. (Pubitemid 351269998)
31. Cauberg EC, Kloen S, Visser M, de la Rosette JJ, Babjuk M, Soukup V, et al. Narrow Band Imaging Cystoscopy Improves the Detection of Non-muscle-invasive Bladder Cancer. Urology 2010;76:658-63.
32. Herr HW, Donat SM. A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences. BJU Int 2008;102:1111-4.
33. Herr HW. Narrow-band imaging cystoscopy to evaluate the response to bacille Calmette-Guerin therapy: preliminary results. BJU Int 2010;105:314-6.
34. Naselli A, Introini C, Bertolotto F, Spina B, Puppo P. Narrow band imaging for detecting residual/recurrent cancerous tissue during second transurethral resection of newly diagnosed non-muscle-invasive high-grade bladder cancer. BJU Int 2010;105:208-11.
35. Herr H, Donat M, Dalbagni G, Taylor J. Narrow-band imaging cystoscopy to evaluate bladder tumours-individual surgeon variability. BJU Int 2010;106:53-5.
36. Zysk AM, Nguyen FT, Oldenburg AL, Marks DL, Boppart SA. Optical coherence tomography: A review of clinical development from bench to bedside. J Biomed Opt 2007;12:051403.
37. Sergeev A, Gelikonov V, Gelikonov G, Feldchtein F, Kuranov R, Gladkova N, et al. In vivo endoscopic OCT imaging of precancer and cancer states of human mucosa. Opt Express 1997;1:432-40.
38. Jesser CA, Boppart SA, Pitris C, Stamper DL, Nielsen GP, Brezinski ME, et al. High resolution imaging of transitional cell carcinoma with optical coherence tomography: feasibility for the evaluation of bladder pathology. Br J Radiol 1999;72:1170-6. (Pubitemid 30028930)
39. Lingley-Papadopoulos CA, Loew MH, Manyak MJ, Zara JM. Computer recognition of cancer in the urinary bladder using optical coherence tomography and texture analysis. J Biomed Opt 2008;13:024003.
40. Hermes B, Spoler F, Naami A, Bornemann J, Forst M, Grosse J, et al. Visualization of the basement membrane zone of the bladder by optical coherence tomography: feasibility of noninvasive evaluation of tumor invasion. Urology 2008;72:677-81.
41. Manyak MJ, Gladkova ND, Makari JH, Schwartz AM, Zagaynova EV, Zolfaghari L, et al. Evaluation of superficial bladder transitional-cell carcinoma by optical coherence tomography. J Endourol 2005;19:570-4. (Pubitemid 40995553)
42. Zagaynova EV, Streltsova OS, Gladkova ND, Snopova LB, Gelikonov GV, Feldchtein FI, Morozov AN. In vivo optical coherence tomography feasibility for bladder disease. J Urol 2002;167:1492-6. (Pubitemid 34132138)
43. Wang Z, Lee CS, Waltzer WC, Liu J, Xie H, Yuan Z, Pan Y. In vivo bladder imaging with microelectromechanical-systems-based endoscopic spectral domain optical coherence tomography. J Biomed Opt 2007;12:034009.
44. Lerner SP, Goh AC, Tresser NJ, Shen SS. Optical coherence tomography as an adjunct to white light cystoscopy for intravesical real-time imaging and staging of bladder cancer. Urology 2008;72:133-7. (Pubitemid 351885393)
45. Ren H, Waltzer WC, Bhalla R, Liu J, Yuan Z, Lee CS, et al. Diagnosis of bladder cancer with microelectromechanical systems-based cystoscopic optical coherence tomography. Urology 2009;74:1351-7.
46. Tearney GJ, Brezinski ME, Southern JF, Bouma BE, Boppart SA, Fujimoto JG. Optical biopsy in human urologic tissue using optical coherence tomography. J Urol 1997;157:1915-9. (Pubitemid 27171810)
47. Pan Y, Lavelle JP, Bastacky SI, Meyers S, Pirtskhalaishvili G, Zeidel ML, et al. Detection of tumorigenesis in rat bladders with optical coherence tomography. Med Phys 2001;28:2432-40. (Pubitemid 34031529)
48. Zagaynova E, Gladkova N, Shakhova N, Gelikonov G, Gelikonov V. Endoscopic OCT with forward-looking probe: clinical studies in urology and gastroenterology. J Biophotonics 2008;1:114-28.
49. Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Bohle A, Palou-Redorta J. EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder. Eur Urol 2008;54:303-14.
50. Wang ZG, Durand DB, Schoenberg M, Pan YT. Fluorescence guided optical coherence tomography for the diagnosis of early bladder cancer in a rat model. J Urol 2005;174:2376-81. (Pubitemid 41611832)
51. Schmidbauer J, Remzi M, Klatte T, Waldert M, Mauermann J, Susani M, et al. Fluorescence Cystoscopy with High-Resolution Optical Coherence Tomography Imaging as an Adjunct Reduces False-Positive Findings in the Diagnosis of Urothelial Carcinoma of the Bladder. Eur Urol 2009;56:914-9.